194 related articles for article (PubMed ID: 19651517)
1. Synthesis and biological evaluation of radioiodinated 2,5-diphenyl-1,3,4-oxadiazoles for detecting beta-amyloid plaques in the brain.
Watanabe H; Ono M; Ikeoka R; Haratake M; Saji H; Nakayama M
Bioorg Med Chem; 2009 Sep; 17(17):6402-6. PubMed ID: 19651517
[TBL] [Abstract][Full Text] [Related]
2. Development of novel beta-amyloid probes based on 3,5-diphenyl-1,2,4-oxadiazole.
Ono M; Haratake M; Saji H; Nakayama M
Bioorg Med Chem; 2008 Jul; 16(14):6867-72. PubMed ID: 18550375
[TBL] [Abstract][Full Text] [Related]
3. Aurones serve as probes of beta-amyloid plaques in Alzheimer's disease.
Ono M; Maya Y; Haratake M; Ito K; Mori H; Nakayama M
Biochem Biophys Res Commun; 2007 Sep; 361(1):116-21. PubMed ID: 17644062
[TBL] [Abstract][Full Text] [Related]
4. Novel chalcones as probes for in vivo imaging of beta-amyloid plaques in Alzheimer's brains.
Ono M; Haratake M; Mori H; Nakayama M
Bioorg Med Chem; 2007 Nov; 15(21):6802-9. PubMed ID: 17826102
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain.
Zhuang ZP; Kung MP; Wilson A; Lee CW; Plössl K; Hou C; Holtzman DM; Kung HF
J Med Chem; 2003 Jan; 46(2):237-43. PubMed ID: 12519062
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship of chalcones and related derivatives as ligands for detecting of beta-amyloid plaques in the brain.
Ono M; Hori M; Haratake M; Tomiyama T; Mori H; Nakayama M
Bioorg Med Chem; 2007 Oct; 15(19):6388-96. PubMed ID: 17644339
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of styrylchromone derivatives as beta-amyloid imaging agents.
Ono M; Maya Y; Haratake M; Nakayama M
Bioorg Med Chem; 2007 Jan; 15(1):444-50. PubMed ID: 17035032
[TBL] [Abstract][Full Text] [Related]
8. Novel benzofuran derivatives for PET imaging of beta-amyloid plaques in Alzheimer's disease brains.
Ono M; Kawashima H; Nonaka A; Kawai T; Haratake M; Mori H; Kung MP; Kung HF; Saji H; Nakayama M
J Med Chem; 2006 May; 49(9):2725-30. PubMed ID: 16640332
[TBL] [Abstract][Full Text] [Related]
9. Diphenylpropynone derivatives as probes for imaging β-amyloid plaques in Alzheimer's brains.
Ono M; Watanabe H; Watanabe R; Haratake M; Nakayama M; Saji H
Bioorg Med Chem Lett; 2011 Jan; 21(1):117-20. PubMed ID: 21145738
[TBL] [Abstract][Full Text] [Related]
10. Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes.
Nilsson KP; Aslund A; Berg I; Nyström S; Konradsson P; Herland A; Inganäs O; Stabo-Eeg F; Lindgren M; Westermark GT; Lannfelt L; Nilsson LN; Hammarström P
ACS Chem Biol; 2007 Aug; 2(8):553-60. PubMed ID: 17672509
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse models.
van Groen T; Kadish I; Wiesehan K; Funke SA; Willbold D
ChemMedChem; 2009 Feb; 4(2):276-82. PubMed ID: 19072935
[TBL] [Abstract][Full Text] [Related]
12. [(18)F]-labeled isoindol-1-one and isoindol-1,3-dione derivatives as potential PET imaging agents for detection of beta-amyloid fibrils.
Lee JH; Byeon SR; Kim Y; Lim SJ; Oh SJ; Moon DH; Yoo KH; Chung BY; Kim DJ
Bioorg Med Chem Lett; 2008 Oct; 18(20):5701-4. PubMed ID: 18835777
[TBL] [Abstract][Full Text] [Related]
13. Imaging and spatial distribution of beta-amyloid peptide and metal ions in Alzheimer's plaques by laser ablation-inductively coupled plasma-mass spectrometry.
Hutchinson RW; Cox AG; McLeod CW; Marshall PS; Harper A; Dawson EL; Howlett DR
Anal Biochem; 2005 Nov; 346(2):225-33. PubMed ID: 16214103
[TBL] [Abstract][Full Text] [Related]
14. Novel 18F-labeled benzofuran derivatives with improved properties for positron emission tomography (PET) imaging of β-amyloid plaques in Alzheimer's brains.
Ono M; Cheng Y; Kimura H; Cui M; Kagawa S; Nishii R; Saji H
J Med Chem; 2011 Apr; 54(8):2971-9. PubMed ID: 21428407
[TBL] [Abstract][Full Text] [Related]
15. Styryl-based compounds as potential in vivo imaging agents for beta-amyloid plaques.
Li Q; Min J; Ahn YH; Namm J; Kim EM; Lui R; Kim HY; Ji Y; Wu H; Wisniewski T; Chang YT
Chembiochem; 2007 Sep; 8(14):1679-87. PubMed ID: 17705341
[TBL] [Abstract][Full Text] [Related]
16. Novel quinoxaline derivatives for in vivo imaging of β-amyloid plaques in the brain.
Cui M; Ono M; Kimura H; Liu B; Saji H
Bioorg Med Chem Lett; 2011 Jul; 21(14):4193-6. PubMed ID: 21684159
[TBL] [Abstract][Full Text] [Related]
17. Quantification of the A beta peptide in Alzheimer's plaques by laser dissection microscopy combined with mass spectrometry.
Rüfenacht P; Güntert A; Bohrmann B; Ducret A; Döbeli H
J Mass Spectrom; 2005 Feb; 40(2):193-201. PubMed ID: 15706631
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease.
Ono M; Haratake M; Nakayama M; Kaneko Y; Kawabata K; Mori H; Kung MP; Kung HF
Nucl Med Biol; 2005 May; 32(4):329-35. PubMed ID: 15878502
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and structure-activity relationship of novel thiophene derivatives for beta-amyloid plaque imaging.
Chandra R; Kung MP; Kung HF
Bioorg Med Chem Lett; 2006 Mar; 16(5):1350-2. PubMed ID: 16325402
[TBL] [Abstract][Full Text] [Related]
20. Diversity of Abeta deposits in the aged brain: a window on molecular heterogeneity?
Walker LC; Rosen RF; Levine H
Rom J Morphol Embryol; 2008; 49(1):5-11. PubMed ID: 18273496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
